Class of QTc Interval Duration and Clinical Features of Patients in Six Months after Pacemakers Implantation

Nikolay I. Yabluchansky, Maria S. Maltseva, Dmitriy E. Volkov, Dmitriy A. Lopin

Abstract


Clinical features of 36 patients (24 men and 12 women ) aged 67 ± 10 (p ( M ± sd)) were investigated before, in the acute postoperative period (3-5 days) and six months after pacemaker implantation in classes of normal (320-440 ms) - 14 ( 39%) and elongated ( > 440 ms ) - 22 (61%) QTc interval duration. Incidence of chronic forms of ischemic heart disease (CIHD) - myocardial infarction and stable angina functional classes (FC) (I-IV); stages (I-III) and degrees (1-3) of arterial hypertension (AH), the type of diabetes mellitus (DM); forms of atrial fibrillation (AF) (paroxysmal and persistent, permanent); chronic heart failure (CHF) FC (I-IV) according to the classification of the New York Heart Association (NYHA) and stages (I-III) of classification N.D. Strazhesko and V.H. Vasilenko are evaluated. Standard statistical procedures using Microsoft Excel are applied. The results have shown a decrease in FC stable angina, AH degrees, FC and stages of CHF in the class of normal QTc interval duration and an increase in the class of prolonging QTc interval duration. Patients need more frequent monitoring pacemaker parameters and strengthening of drug therapy, especially in patients with an elongated QTc interval in the first six months after pacemaker implantation.


Volltext:

PDF (Russian)

Literaturhinweise


2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society: Circulation. 2013;127:e283-e352Chugh S. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study / S. Chugh, K. Reinier, T. Singh [et al.]: Circulation. 2009. №119; 663–670.

John A. Chiladakis. Facilitating assessment of QT interval duration during ventricular pacing/ John A. Chiladakis, Dimitrios Alexopoulos: Europace (2013) 15 (6); 907-914.

Moss A. Long QT syndrome / A. Moss, J. Robinson: Heart Dis. Stroke. 1992. № 1; 309–314.

Cardiovascular disease. Classification standards for diagnosis and treatment of cardiac patients / Edited by prof. V. Kovalenko, prof. MI Lutay Sci. M. Sirenko. K.: PP AMB, 2007; 128.

Sagie A. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) / A. Sagie, M. Larson, R. Goldberg [et al.]: Am. J. Cardiol. 1992. №70; 797–801.

Berger T, Hanser F, Hintringer F, Poelzl G, Fischer G, Modre R, Tilg B, Pachinger O, Roithinger FX. Effects of cardiac resynchronization therapy on ventricular repolarization in patients with congestive heart failure/ J Cardiovasc Electrophysiol. 2005 Jun;16(6): 611-7.

Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators/ J Interv Card Electrophysiol. 1998 Jun;2(2):121-35.

Cardiovascular disease. Classification standards for diagnosis and treatment of cardiac patients: Edited by prof. V. Kovalenko, prof. MI Lutay Sci. M. Sirenko - K.: PP AMB, 2007; 128.


Refbacks